Antimycobacterial activity of natural products and synthetic agents: Pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis

被引:67
|
作者
Ganihigama, Dakshina U. [1 ]
Sureram, Sanya [2 ]
Sangher, Sasithorn [2 ]
Hongmanee, Poonpilas [3 ]
Aree, Thammarat [4 ]
Mahidol, Chulabhorn [1 ,2 ]
Ruchirawat, Somsak [1 ,2 ,5 ]
Kittakoop, Prasat [1 ,2 ,5 ]
机构
[1] Chulabhorn Grad Inst, Chem Biol Program, Bangkok 10210, Thailand
[2] Chulabhorn Res Inst, Bangkok 10210, Thailand
[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Microbiol,Dept Pathol, Bangkok 10400, Thailand
[4] Chulalongkorn Univ, Fac Sci, Dept Chem, Bangkok 10330, Thailand
[5] Ctr Excellence Environm Hlth & Toxicol EHT, CHE, Minist Educ, Bangkok, Thailand
关键词
Antimycobacterial activity; Mycobacterium tuberculosis; Multidrug resistant tuberculosis; Natural product; Antimycobacterial compound; Microwave-assisted synthesis; SECONDARY METABOLITES; ALKALOIDS; ANALOGS; DESIGN; PLANTS; FUNGI;
D O I
10.1016/j.ejmech.2014.10.026
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Various classes of natural products and synthetic compounds were tested against reference strains and clinical multidrug resistant isolates of Mycobacterium tuberculosis. Vermelhotin (19), a natural tetramic acid from fungi, was the most active toward clinical MDR TB isolates (MIC 1.5-12.5 mu g/mL). Synthetic compounds (i.e. benzoxazocines, coumarins, chromenes, and pyrrolodiquinoline derivatives) were prepared by green chemistry approaches. Under microwave irradiation, a one-pot synthesis of pyrrolodiquinoline 85 was achieved by homocoupling of 1-methylquinolinium iodide; the structure of 85 was confirmed by single-crystal X-ray analysis. Compound 85 and its derivative 86 exhibited potent antitubercular activity (MIC 0.3-6.2 mu g/mL) against clinical MDR TB isolates, and they displayed weak cytotoxicity toward normal cell line. The scaffold of 85 and 86 is potential for antimycobacterial activity. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [41] Synthesis, pharmacokinetic and molecular docking studies of new benzohydrazide derivatives possessing anti-tubercular activity against Mycobacterium tuberculosis H37Rv
    Lalavani, Nilam H.
    Gandhi, Himani R.
    Bhensdadia, Krishna A.
    Patel, Rajesh K.
    Baluja, Shipra H.
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1250
  • [42] In vitro growth inhibition and bactericidal activity of spathulenol against drug-resistant clinical isolates of Mycobacterium tuberculosis
    de Jesus Dzul-Beh, Angel
    Garcia-Sosa, Karlina
    Humberto Uc-Cachon, Andres
    Borquez, Jorge
    Loyola, Luis A.
    Barrios-Garcia, Hugo B.
    Manuel Pena-Rodriguez, Luis
    Maria Molina-Salinas, Gloria
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2019, 29 (06): : 798 - 800
  • [43] In vitro growth inhibition and bactericidal activity of spathulenol against drug-resistant clinical isolates of Mycobacterium tuberculosis
    Angel Jesús de Dzul-Beh
    Karlina García-Sosa
    Andrés Humberto Uc-Cachón
    Jorge Bórquez
    Luis A. Loyola
    Hugo B. Barrios-García
    Luis Manuel Peña-Rodríguez
    Gloria María Molina-Salinas
    Revista Brasileira de Farmacognosia, 2019, 29 : 798 - 800
  • [44] Evaluation of Azithromycin and Fenugreek Oil as Anti-virulence Agents against Stenotrophomonas maltophilia MultiDrug Resistant Clinical Isolates
    El-Soudany, Ingy
    Elsheikh, Azza
    Abdelwahab, Ibrahim A.
    EGYPTIAN JOURNAL OF BOTANY, 2024, 64 (01): : 329 - 340
  • [45] Antitubercular and Antibacterial Activity of Quinonoid Natural Products Against Multi-Drug Resistant Clinical Isolates
    Dey, Diganta
    Ray, Ratnamala
    Hazra, Banasri
    PHYTOTHERAPY RESEARCH, 2014, 28 (07) : 1014 - 1021
  • [46] Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products
    Nora de Souza, Marcus Vinicius
    FITOTERAPIA, 2009, 80 (08) : 453 - 460
  • [47] Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis
    Mestdagh, M
    Fonteyne, PA
    Realini, L
    Rossau, R
    Jannes, G
    Mijs, W
    De Smet, KAL
    Portaels, F
    Van den Eeckhout, E
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) : 2317 - 2319
  • [48] Declining trend of resistance to first-line anti-tubercular drugs in clinical isolates of Mycobacterium tuberculosis in a tertiary care north Indian hospital after implementation of revised national Tuberculosis control programme
    Jain, A.
    Diwakar, P.
    Singh, U.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 32 (04) : 430 - 433
  • [49] Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis
    Habibnia, Shadi
    Karami-Zarandi, Morteza
    Zaker, Saeed
    Ghalavand, Zohreh
    Doustdar, Farahnoosh
    Eslami, Gita
    Kazemian, Hossein
    CLINICAL LABORATORY, 2023, 69 (01) : 33 - 40
  • [50] In Vitro Evaluation of Palestinian Propolis as a Natural Product with Antioxidant Properties and Antimicrobial Activity against Multidrug-Resistant Clinical Isolates
    Daraghmeh, Jamila
    Imtara, Hamada
    JOURNAL OF FOOD QUALITY, 2020, 2020